Cholangiocarcinomas Completed Phase 2 Trials for Erlotinib (DB00530)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00350753Avastin and Tarceva for Upper Gastrointestinal CancersTreatment